Argentina: Research took the first step towards reducing cases of cancer in cattle

Published 2023년 3월 6일

Tridge summary

A recent study by the National Institute of Agricultural Technology (INTA) and the National Council for Scientific and Technical Research (Conicet) in Argentina has unraveled the molecular mechanism behind the bovine leukosis virus (BLV) causing tumors in cattle, particularly lymphoma. This finding is crucial as there is no commercial treatment or vaccine for the pathogen, leading to significant economic losses. The study, published in Plos One, suggests that small molecules called microRNAs synthesized by the virus might be the key to tumor induction by downregulating a molecule with antitumor properties (PXDN). This discovery is a significant step towards developing prevention or treatment strategies for bovine lymphoma.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

A joint study by specialists from the National Institute of Agricultural Technology (INTA) and the National Council for Scientific and Technical Research (Conicet), both from Argentina, described, for the first time, a molecular mechanism by which the bovine leukosis virus (BLV) triggers the development of tumors in cattle. One fact to bear in mind is that, due to the lack of a commercial treatment or vaccine against this pathogen, economic losses amount to millions of dollars. Juan Pablo Jaworski, study director and researcher at Conicet, described this work. "The research helps to understand neoplastic induction processes induced by VLB and which in bovines give rise to a type of cancer called lymphoma", he said. He added, "The molecular factors we describe may eventually be translated into prevention or treatment strategies in the future, but further study is still needed." Bovine leukosis is widespread in dairy herds, but also in meat production herds. Although a high ...
Source: Milkpoint

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.